Delivery Technologies

AquaCelle® is a patent-pending, clinically-validated self micro-emulsifying drug delivery system (SMEDDS), specifically designed to increase the bioavailability of lipophilic actives.

A need for greater bioavailability

Bioavailability and absorption of ingredients is an important issue for many dietary supplements in the market. The higher the bioavailability of a nutrient, the more that nutrient can be absorbed and benefit the body. For the human body to receive maximum benefits from lipophilic actives (fat-soluble ingredients)—such as Lutein, Resveratrol, Curcumin, and Omega-3s—they must be surrounded with an emulsifier to make them more bioavailable and absorbable.

AquaCelle® is a trademark of Pharmako Biotechnologies Pty Ltd.

What is the AquaCelle® micro-emulsifying nutrient delivery system?

AquaCelle® is a lipid based formulation that self-assembles into a micellar colloidal delivery system in aqueous environments (such as the stomach) at body temperature. These micelles are what envelop fat-soluble ingredients, helping their benefits to be absorbed more fully into the body.

The body has its own built-in capacity to make fat-soluble ingredients absorbable. Using the liver to form bile acids and then bile salts, the body then secretes these salts to surround molecules of fat-soluble ingredients to allow them to be absorbed by the small intestine. The formation of micelles is time-consuming and waits on bile salts to form, be secreted, and form micelles before each ingredient can be properly and beneficially absorbed, leaving room for fat-soluble nutrients to be damaged by stomach acids while waiting.
AquaCelle® is designed to more efficiently create these micelles, delivering better absorption and a more efficacious finished product for the consumer.

Approved Health Claims:

Aquacelle Omega-3

Pharmacokinetic Study

Learn More...

Aquacelle CoQ10

Pharmacokinetic Study

Learn More...

Learn more about AquaCelle®

Download PDF

AquaCelle® in the news

Technology Fuels Omega-3 Growth

Aquacelle Delivery Technology Shown to Improve Omega 3 Absorption

The evolving demand for delivery innovations

LipiSperse® advanced dispersion technology

Our award winning LipiSperse® is an advanced cold water dispersion technology(CWD).  Allowing solid lipophilic active ingredients with otherwise relatively low bioavailability & poor solubility in water, to be easily dispersed in cold water, thereby increasing their bioavailability and uptake in the body.

LipiSperse® is a trademark of Pharmako Biotechnologies Pty Ltd.

Lipisperse Advantages:


Curcumin with increased Bioavailability
A New Approach to Benefiting the Endocannabinoid System
Cold water dispersible (CWD) resveratrol powder

Learn more about LipiSperse®

Download PDF

LipiSperse® in the news

Delivery Technologies for Improved Bioavailability of Lipophilic Activities

Gencor introduces dispersible resveratrol ingredient with LipiSperse technology

NutraVideo: Eric Meppem on bioavailability challenges, LipiSperse technology


Pharmako's Compressible Powdered Oils (CPOs) are an ingenious material development that allow oily active ingredients to be included in tablet & powder formulations without leaching of the oil.

CPO Applications:

Astaxanthin CPO

Pharmako's CPO Astaxanthin extends the formatting range of this novel ingredient.  With our development, astaxanthin is now able to be utilised in tablet & powder formulations with a high 4% concentration and superior stability.

Learn More...

Lavender CPO

Pharmako's CPO Lavender is a progressive material development that allows lavender oil to be converted into a powder with a 50% loading. The powder is not sensitive to temperature and pressure, with a high linalool and linalyl acetate concentration.

Learn More...

Learn more about CPO

Download PDF